203 related articles for article (PubMed ID: 25182642)
1. Zidovudine induces downregulation of mitochondrial deoxynucleoside kinases: implications for mitochondrial toxicity of antiviral nucleoside analogs.
Sun R; Eriksson S; Wang L
Antimicrob Agents Chemother; 2014 Nov; 58(11):6758-66. PubMed ID: 25182642
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of mitochondrial thymidine kinase 2 and deoxyguanosine kinase by didanosine: implication for mitochondrial toxicities of anti-HIV nucleoside analogs.
Sun R; Eriksson S; Wang L
Biochem Biophys Res Commun; 2014 Jul; 450(2):1021-6. PubMed ID: 24976398
[TBL] [Abstract][Full Text] [Related]
3. Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs.
Rylova SN; Albertioni F; Flygh G; Eriksson S
Biochem Pharmacol; 2005 Mar; 69(6):951-60. PubMed ID: 15748706
[TBL] [Abstract][Full Text] [Related]
4. The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs.
Wang L; Sun R; Eriksson S
Antimicrob Agents Chemother; 2011 Jun; 55(6):2552-8. PubMed ID: 21444706
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial thymidine kinase 2 but not deoxyguanosine kinase is up-regulated during the stationary growth phase of cultured cells.
Sun R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):282-6. PubMed ID: 24940680
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
Priego EM; Karlsson A; Gago F; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
Curr Pharm Des; 2012; 18(20):2981-94. PubMed ID: 22571666
[TBL] [Abstract][Full Text] [Related]
7. Deoxyribonucleoside kinases in mitochondrial DNA depletion.
Saada-Reisch A
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1205-15. PubMed ID: 15571232
[TBL] [Abstract][Full Text] [Related]
8. Expression of deoxynucleoside kinases and 5'-nucleotidases in mouse tissues: implications for mitochondrial toxicity.
Rylova SN; Mirzaee S; Albertioni F; Eriksson S
Biochem Pharmacol; 2007 Jun; 74(1):169-75. PubMed ID: 17493587
[TBL] [Abstract][Full Text] [Related]
9. The enantioselectivity of the cellular deoxynucleoside kinases.
Wang J; Chattopadhyaya J; Eriksson S
Nucleosides Nucleotides; 1999; 18(4-5):807-10. PubMed ID: 10432682
[TBL] [Abstract][Full Text] [Related]
10. Stereoisomeric selectivity of human deoxyribonucleoside kinases.
Wang J; Choudhury D; Chattopadhyaya J; Eriksson S
Biochemistry; 1999 Dec; 38(51):16993-9. PubMed ID: 10606535
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of mitochondrial factors modulating thymidine kinase 2 activity.
Sun R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):382-5. PubMed ID: 20544523
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of isocarbostyril- and difluorophenyl-nucleoside thymidine mimics by the human deoxynucleoside kinases.
Al-Madhoun AS; Eriksson S; Wang ZX; Naimi E; Knaus EE; Wiebe LI
Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1865-74. PubMed ID: 15628745
[TBL] [Abstract][Full Text] [Related]
13. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
[TBL] [Abstract][Full Text] [Related]
14. Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future.
Pérez-Pérez MJ; Priego EM; Hernández AI; Familiar O; Camarasa MJ; Negri A; Gago F; Balzarini J
Med Res Rev; 2008 Sep; 28(5):797-820. PubMed ID: 18459168
[TBL] [Abstract][Full Text] [Related]
15. The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs.
Sun R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1347-1358. PubMed ID: 32189555
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
[TBL] [Abstract][Full Text] [Related]
17. Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
Curbo S; Johansson M; Balzarini J; Lewis LD; Karlsson A
Exp Cell Res; 2009 Sep; 315(15):2539-43. PubMed ID: 19481540
[TBL] [Abstract][Full Text] [Related]
18. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.
Wang L; Limongelli A; Vila MR; Carrara F; Zeviani M; Eriksson S
Mol Genet Metab; 2005 Jan; 84(1):75-82. PubMed ID: 15639197
[TBL] [Abstract][Full Text] [Related]
19. Altered gene transcription profiles in fibroblasts harboring either TK2 or DGUOK mutations indicate compensatory mechanisms.
Villarroya J; de Bolós C; Meseguer A; Hirano M; Vilà MR
Exp Cell Res; 2009 May; 315(8):1429-38. PubMed ID: 19265691
[TBL] [Abstract][Full Text] [Related]
20. Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.
Villarroya J; Lara MC; Dorado B; Garrido M; García-Arumí E; Meseguer A; Hirano M; Vilà MR
Biochem Biophys Res Commun; 2011 Apr; 407(2):333-8. PubMed ID: 21382338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
